menu
    • menu

    Company profile for 180 Life Sciences

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    180 Life Sciences is developing new treatments for one of the world's biggest drivers of disease: inflammation. The company consists of three programs developing novel drugs for treating distinct inflammatory diseases. These programs are led by world-leading scientists at prestigious universities who have already developed blockbuster drugs and made ground-breaking discoveries in their fields. One of the programs is conductin...
    180 Life Sciences is developing new treatments for one of the world's biggest drivers of disease: inflammation. The company consists of three programs developing novel drugs for treating distinct inflammatory diseases. These programs are led by world-leading scientists at prestigious universities who have already developed blockbuster drugs and made ground-breaking discoveries in their fields. One of the programs is conducting a phase 2b/3 trial and expects its first results in Q4 2021. Other clinical trials are expected to begin by the end of 2021.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    180 Life SciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3000 El Camino Real Bldg. 4, Suite 200 Palo Alto, CA 94306
    Telephone
    Telephone
    (650) 507-0669
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://180lifesciences.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/180-life-sciences/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    180 Life Sciences Closes $156 Million Convertible Notes Offering
    180 Life Sciences Closes $156 Million Convertible Notes Offering

    11 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/180-life-sciences-announces-closing-of-private-offering-of-approximately-156-million-of-convertible-notes-302526399.html

    PR NEWSWIRE
    11 Aug 2025
    Share Share
    180 Life Sciences Corp. Strengthens Legacy Intellectual Property
    180 Life Sciences Corp. Strengthens Legacy Intellectual Property

    01 Jul 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/biotechnology/180-life-sciences-corp.-announces-strengthening-of-legacy-intellectual-property-asset-1044620

    ACCESSWIRE
    01 Jul 2025
    Share Share
    180 Life Gets US Patent for Post-Op Cognitive Disorder
    180 Life Gets US Patent for Post-Op Cognitive Disorder

    01 May 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/180-life-sciences-corp.-announces-notice-of-allowance-for-u.s.-patent-1022250

    ACCESSWIRE
    01 May 2025
    Share Share
    180 Life Sciences Corp. Announces Share Repurchase
    180 Life Sciences Corp. Announces Share Repurchase

    30 Apr 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/180-life-sciences-corp.-announces-share-repurchase-1021585

    ACCESSWIRE
    30 Apr 2025
    Share Share
    180 Life Sciences Prices $2.9 M Offering and Private Placement
    180 Life Sciences Prices $2.9 M Offering and Private Placement

    27 Dec 2024

    // ACCESSWIRE

    https://www.accesswire.com/960392/180-life-sciences-corp-announces-pricing-of-29-million-registered-direct-offering-and-concurrent-private-placement-priced-at-the-market-under-nasdaq-rules

    ACCESSWIRE
    27 Dec 2024
    Share Share
    180 Life Sciences Regains Compliance With Nasdaq Listing Rules
    180 Life Sciences Regains Compliance With Nasdaq Listing Rules

    12 Dec 2024

    // ACCESSWIRE

    https://www.accesswire.com/953814/180-life-sciences-corp-regains-full-compliance-with-nasdaq-continued-listing-rules

    ACCESSWIRE
    12 Dec 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search